Search Results - "Shen, Marina W H"
-
1
Indole Cytosolic Phospholipase A2 α Inhibitors: Discovery and in Vitro and in Vivo Characterization of 4-{3-[5-Chloro-2-(2-{[(3,4-dichlorobenzyl)sulfonyl]amino}ethyl)-1-(diphenylmethyl)-1H-indol-3-yl]propyl}benzoic Acid, Efipladib
Published in Journal of medicinal chemistry (26-06-2008)“…The optimization of a class of indole cPLA2α inhibitors is described herein. The importance of the substituent at C3 and the substitution pattern of the…”
Get full text
Journal Article -
2
Discovery of Clinical Candidate 1‑{[(2S,3S,4S)‑3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin‑1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based Drug Design
Published in Journal of medicinal chemistry (13-07-2017)“…Through fragment-based drug design focused on engaging the active site of IRAK4 and leveraging three-dimensional topology in a ligand-efficient manner, a…”
Get full text
Journal Article -
3
Discovery of Ecopladib, an Indole Inhibitor of Cytosolic Phospholipase Α2α
Published in Journal of medicinal chemistry (22-03-2007)“…The synthesis and structure−activity relationship of a series of indole inhibitors of cytosolic phospholipase A2α (cPLA2α, type IVA phospholipase) are…”
Get full text
Journal Article -
4
Inhibition of Cytosolic Phospholipase A2α: Hit to Lead Optimization
Published in Journal of medicinal chemistry (12-01-2006)“…Compound 1 was previously reported to be a potent inhibitor of cPLA2α in both artificial monomeric substrate and cell-based assays. However, 1 was inactive in…”
Get full text
Journal Article -
5
Cytosolic phospholipase A2 alpha-deficient mice are resistant to experimental autoimmune encephalomyelitis
Published in The Journal of experimental medicine (19-09-2005)“…Experimental autoimmune encephalomyelitis (EAE), a Th1-mediated inflammatory disease of the central nervous system (CNS), is a model of human multiple…”
Get full text
Journal Article -
6
Discovery of ecopladib, an indole inhibitor of cytosolic phospholipase A2α
Published in Journal of medicinal chemistry (22-03-2007)Get full text
Journal Article -
7
Blockade of cytosolic phospholipase A2 α prevents experimental autoimmune encephalomyelitis and diminishes development of Th1 and Th17 responses
Published in Journal of neuroimmunology (15-11-2008)“…Abstract Cytosolic phospholipase A2 α (cPLA2 α) is the rate-limiting enzyme for release of arachidonic acid, which is converted primarily to prostaglandins via…”
Get full text
Journal Article -
8
Benzhydrylquinazolinediones: Novel cytosolic phospholipase A2α inhibitors with improved physicochemical properties
Published in Bioorganic & medicinal chemistry (01-07-2009)Get full text
Journal Article -
9
Reactions of Functionalized Sulfonamides: Application to Lowering the Lipophilicity of Cytosolic Phospholipase A 2 α Inhibitors
Published in Journal of medicinal chemistry (26-02-2009)Get full text
Journal Article -
10
A fluorescence-based assay for fatty acid amide hydrolase compatible with high-throughput screening
Published in Analytical biochemistry (01-08-2005)“…A novel fluorescent assay to continuously monitor fatty acid amide hydrolase (FAAH) activity that is simple, sensitive, and amenable to high-throughput…”
Get full text
Journal Article -
11
The cPLA2α inhibitor efipladib decreases nociceptive responses without affecting PGE2 levels in the cerebral spinal fluid
Published in Neuropharmacology (01-03-2011)“…The contribution of central PGE(2) levels to the nociceptive response in rats was assessed and the effects of the selective cPLA(2)α inhibitor efipladib, and…”
Get full text
Journal Article -
12
-
13
Thermodynamic characterization of cytosolic phospholipase A2 alpha inhibitors
Published in Analytical biochemistry (15-12-2008)“…Cytosolic phospholipase A(2) alpha (cPLA(2)alpha, type IVA phospholipase) acts at the membrane surface to release free arachidonic acid, which is metabolized…”
Get full text
Journal Article -
14
Reactions of Functionalized Sulfonamides: Application to Lowering the Lipophilicity of Cytosolic Phospholipase A2α Inhibitors
Published in Journal of medicinal chemistry (26-02-2009)“…The cPLA2α inhibitors we reported earlier were potent in both isolated enzyme and rat whole blood assays but have high plogD7.4. To address these issues,…”
Get full text
Journal Article -
15
Indole Cytosolic Phospholipase A 2 α Inhibitors: Discovery and in Vitro and in Vivo Characterization of 4-{3-[5-Chloro-2-(2-{[(3,4-dichlorobenzyl)sulfonyl]amino}ethyl)-1-(diphenylmethyl)-1 H -indol-3-yl]propyl}benzoic Acid, Efipladib
Published in Journal of medicinal chemistry (01-06-2008)Get full text
Journal Article -
16
Discovery of Ecopladib, an indole inhibitor of cytosolic phospholipase A2alpha
Published in Journal of medicinal chemistry (22-03-2007)“…The synthesis and structure-activity relationship of a series of indole inhibitors of cytosolic phospholipase A2alpha (cPLA2alpha, type IVA phospholipase) are…”
Get full text
Journal Article -
17
Discovery of Ecopladib, an Indole Inhibitor of Cytosolic Phospholipase Α 2 α
Published in Journal of medicinal chemistry (01-03-2007)Get full text
Journal Article -
18
Indole Cytosolic Phospholipase A2 α Inhibitors : Discovery and in Vitro and in Vivo Characterization of 4-{3-[5-Chloro-2-(2-{[(3,4-dichlorobenzyl)sulfonyl]amino}ethyl)-l-(diphenylmethyl)-1H-indol-3-yl]propyl}benzoic Acid, Efipladib
Published in Journal of medicinal chemistry (2008)Get full text
Journal Article -
19
Inhibition of cytosolic phospholipase A2alpha: hit to lead optimization
Published in Journal of medicinal chemistry (12-01-2006)“…Compound 1 was previously reported to be a potent inhibitor of cPLA(2)alpha in both artificial monomeric substrate and cell-based assays. However, 1 was…”
Get full text
Journal Article -
20
Inhibition of Cytosolic Phospholipase A 2 α: Hit to Lead Optimization
Published in Journal of medicinal chemistry (01-01-2006)Get full text
Journal Article